Carregant...
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
BACKGROUND: Platinum salts have demonstrated sufficient efficacy and safety for consideration of their use in a neoadjuvant setting for triple negative breast cancer (TNBC). PATIENTS AND METHODS: We retrospectively analyzed 145 TNBC cases to compare the activity and tolerability of cisplatin and car...
Guardat en:
| Publicat a: | Onco Targets Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5716301/ https://ncbi.nlm.nih.gov/pubmed/29238206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S145934 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|